Cigna Investments’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $260K | Sell |
2,202
-104
| -5% | -$12K | 0.03% | 397 |
|
|
2026
Q1 | $276K | Sell |
2,306
-69
| -3% | -$9.05K | 0.04% | 359 |
|
|
2025
Q4 | $323K | Hold |
2,375
| – | – | 0.05% | 331 |
|
|
2025
Q3 | $350K | Hold |
2,375
| – | – | 0.05% | 312 |
|
|
2025
Q2 | $308K | Sell |
2,375
-38
| -2% | -$4.6K | 0.05% | 337 |
|
|
2025
Q1 | $289K | Sell |
2,413
-38
| -2% | -$4.71K | 0.05% | 343 |
|
|
2024
Q4 | $284K | Sell |
2,451
-54
| -2% | -$6.83K | 0.05% | 360 |
|
|
2024
Q3 | $338K | Hold |
2,505
| – | – | 0.06% | 321 |
|
|
2024
Q2 | $339K | Sell |
2,505
-32
| -1% | -$4.35K | 0.06% | 309 |
|
|
2024
Q1 | $327K | Hold |
2,537
| – | – | 0.06% | 317 |
|
|
2023
Q4 | $290K | Hold |
2,537
| – | – | 0.06% | 332 |
|
|
2023
Q3 | $231K | Sell |
2,537
-327
| -11% | -$33.7K | 0.05% | 372 |
|
|
2023
Q2 | $323K | Buy |
2,864
+700
| +32% | +$74K | 0.06% | 333 |
|
|
2023
Q1 | $227K | Sell |
2,164
-27
| -1% | -$2.82K | 0.05% | 401 |
|
|
2022
Q4 | $242K | Buy |
+2,191
| New | +$230K | 0.05% | 383 |
|
|
2022
Q2 | – | Sell |
-3,112
| Closed | -$265K | – | 584 |
|
|
2022
Q1 | $265K | Sell |
3,112
-957
| -24% | -$91.7K | 0.03% | 486 |
|
|
2021
Q4 | $488K | Sell |
4,069
-1,440
| -26% | -$179K | 0.04% | 376 |
|
|
2021
Q3 | $681K | Sell |
5,509
-100
| -2% | -$12.9K | 0.05% | 337 |
|
|
2021
Q2 | $673K | Sell |
5,609
-838
| -13% | -$95.7K | 0.05% | 344 |
|
|
2021
Q1 | $679K | Buy |
6,447
+193
| +3% | +$19.6K | 0.05% | 361 |
|
|
2020
Q4 | $636K | Buy |
6,254
+490
| +9% | +$46.1K | 0.05% | 340 |
|
|
2020
Q3 | $485K | Hold |
5,764
| – | – | 0.05% | 352 |
|
|
2020
Q2 | $375K | Buy |
5,764
+711
| +14% | +$46.9K | 0.04% | 477 |
|
|
2020
Q1 | $329K | Buy |
5,053
+340
| +7% | +$26.8K | 0.04% | 431 |
|
|
2019
Q4 | $385K | Sell |
4,713
-583
| -11% | -$45.4K | 0.04% | 448 |
|
|
2019
Q3 | $406K | Buy |
5,296
+300
| +6% | +$23.6K | 0.04% | 449 |
|
|
2019
Q2 | $401K | Sell |
4,996
-200
| -4% | -$15.9K | 0.04% | 447 |
|
|
2019
Q1 | $410K | Sell |
5,196
-100
| -2% | -$7.3K | 0.05% | 435 |
|
|
2018
Q4 | $353K | Sell |
5,296
-19
| -0.4% | -$1.31K | 0.03% | 455 |
|
|
2018
Q3 | $349K | Sell |
5,315
-500
| -9% | -$37.3K | 0.03% | 491 |
|
|
2018
Q2 | $392K | Sell |
5,815
-800
| -12% | -$58.1K | 0.03% | 497 |
|
|
2018
Q1 | $509K | Sell |
6,615
-10
| -0.2% | -$739 | 0.03% | 451 |
|
|
2017
Q4 | $451K | Sell |
6,625
-263
| -4% | -$17.5K | 0.03% | 523 |
|
|
2017
Q3 | $431K | Sell |
6,888
-5
| -0.1% | -$299 | 0.03% | 518 |
|
|
2017
Q2 | $382K | Sell |
6,893
-300
| -4% | -$15.6K | 0.03% | 546 |
|
|
2017
Q1 | $361K | Buy |
7,193
+708
| +11% | +$34.5K | 0.02% | 551 |
|
|
2016
Q4 | $321K | Buy |
+6,485
| New | +$329K | 0.04% | 535 |
|
Other funds holding XYL
Cigna Investments's XYL Position: Q2 2026 in Review
Cigna Investments reduced its Xylem (XYL) stake by 4.5% in Q2 2026, selling an estimated $12K and leaving 2,202 shares worth $260K. The position accounts for 0.03% of the portfolio, ranked #397.
Cigna Investments first reported a position in XYL in Q4 2016 and has held it in 37 quarters since. The position peaked at $681K in Q3 2021. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- Cigna Investments held 2,202 shares of Xylem worth $260K as of Q2 2026.
- Cigna Investments sold 104 Xylem shares in Q2 2026, an estimated $12K.
- Xylem made up 0.03% of Cigna Investments's portfolio in Q2 2026, its #397 holding.
- Cigna Investments first reported a position in Xylem in Q4 2016 and has held it in 37 quarters since.
- Cigna Investments's Xylem position peaked at $681K in Q3 2021.
- 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.